Literature DB >> 7730659

Gene knock-out technology: a methodological overview for the interested novice.

L A Galli-Taliadoros1, J D Sedgwick, S A Wood, H Körner.   

Abstract

Gene targeting by homologous recombination is a powerful technique, generating mouse strains with defined mutations in their genome. These genetically modified, 'designer' animals allow us for the first time to ask simple questions about elaborate and complex biological systems. Dissecting the function of individual components of the immune system is a perfect application of this technology. Although the techniques involved in the generation of gene knock-out mice are increasingly well defined, to many immunologists the language and concepts are confusing. This review presents the essentials of the technology in a form digestible by the non-expert.

Entities:  

Mesh:

Year:  1995        PMID: 7730659     DOI: 10.1016/0022-1759(95)00017-5

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  18 in total

Review 1.  Unlinking tumor necrosis factor biology from the major histocompatibility complex: lessons from human genetics and animal models.

Authors:  S R Ruuls; J D Sedgwick
Journal:  Am J Hum Genet       Date:  1999-08       Impact factor: 11.025

2.  MTCH2/MIMP is a major facilitator of tBID recruitment to mitochondria.

Authors:  Yehudit Zaltsman; Liat Shachnai; Natalie Yivgi-Ohana; Michal Schwarz; Maria Maryanovich; Riekelt H Houtkooper; Frédéric Maxime Vaz; Francesco De Leonardis; Giuseppe Fiermonte; Ferdinando Palmieri; Bernhard Gillissen; Peter T Daniel; Erin Jimenez; Susan Walsh; Carla M Koehler; Soumya Sinha Roy; Ludivine Walter; György Hajnóczky; Atan Gross
Journal:  Nat Cell Biol       Date:  2010-05-02       Impact factor: 28.824

Review 3.  Artificial chromosome-based transgenes in the study of genome function.

Authors:  Jason D Heaney; Sarah K Bronson
Journal:  Mamm Genome       Date:  2006-08-04       Impact factor: 2.957

Review 4.  Probing human cardiovascular congenital disease using transgenic mouse models.

Authors:  Paige Snider; Simon J Conway
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

5.  A ribozyme-mediated, gene "knockdown" strategy for the identification of gene function in zebrafish.

Authors:  Y Xie; X Chen; T E Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

6.  Gene targeting in C57BL/6 ES cells. Successful germ line transmission using recipient BALB/c blastocysts developmentally matured in vitro.

Authors:  F A Lemckert; J D Sedgwick; H Körner
Journal:  Nucleic Acids Res       Date:  1997-02-15       Impact factor: 16.971

7.  A Novel Rat Model of Nonalcoholic Fatty Liver Disease Constructed Through CRISPR/Cas-Based Hydrodynamic Injection.

Authors:  Qin Yu; Rui-Zhi Tan; Quan Gan; Xia Zhong; You-Qiang Wang; Jing Zhou; Li Wang
Journal:  Mol Biotechnol       Date:  2017-10       Impact factor: 2.695

8.  FAT10/diubiquitin-like protein-deficient mice exhibit minimal phenotypic differences.

Authors:  Allon Canaan; Xiaofeng Yu; Carmen J Booth; Jin Lian; Isaac Lazar; Serwa L Gamfi; Katrina Castille; Naohiko Kohya; Yasuhiro Nakayama; Yuan-Ching Liu; Elizabeth Eynon; Richard Flavell; Sherman M Weissman
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

9.  A vascular gene trap screen defines RasGRP3 as an angiogenesis-regulated gene required for the endothelial response to phorbol esters.

Authors:  David M Roberts; Amanda L Anderson; Michihiro Hidaka; Raymond L Swetenburg; Cam Patterson; William L Stanford; Victoria L Bautch
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

10.  Neutrophil-selective CD18 silencing using RNA interference in vivo.

Authors:  Xavier Cullere; Michael Lauterbach; Naotake Tsuboi; Tanya N Mayadas
Journal:  Blood       Date:  2008-01-23       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.